PET-CT阳性纵隔淋巴结的EBUS-TBNA细胞学评估:大型癌症中心经验
该研究回顾性分析了2015年全年经EBUS-TBNA获取的2267枚纵隔淋巴结,其中577枚为PET-CT阳性。46%为细胞学恶性,54%为良性;恶性组淋巴结平均尺寸更大(14.6 mm vs 9.58 mm),平均SUV更高(10.05 vs 5.99)。结论认为PET-CT阳性 alone 对恶性不特异,结合淋巴结大小和SUV可提高特异性。
要点
- PET-CT阳性纵隔淋巴结中仅46%细胞学证实为恶性。
- 细胞学恶性组淋巴结平均尺寸更大(14.6 mm vs 9.58 mm)且SUV更高(10.05 vs 5.99)。
- 良性组中显著细胞学表现为坏死和肉芽肿性炎,包括3例真菌。
核心结论
- PET-CT阳性 alone 对纵隔淋巴结恶性不特异,不足以指导管理。
- 结合淋巴结大小和SUV值可提高PET-CT阳性淋巴结的诊断特异性。
研究设计与样本
- 共2267枚纵隔淋巴结,其中577枚符合PET-CT阳性标准并纳入分析。
主要发现
- 577枚PET-CT阳性淋巴结中,263枚(46%)为细胞学恶性,314枚(54%)为细胞学良性。
- 细胞学恶性组所有患者均有既往或同时恶性肿瘤诊断,而良性组为89%。
- 224例细胞学恶性患者中,177例(79%)为肺原发转移,43例(19%)为非肺原发转移,7例(3%)为淋巴瘤。
- 细胞学恶性组淋巴结平均尺寸14.6 mm,良性组9.58 mm;平均SUV分别为10.05和5.99。
- 细胞学良性组显著细胞学发现为坏死和肉芽肿性炎,包括3例真菌。
临床怎么用
- PET-CT阳性纵隔淋巴结需经EBUS-TBNA细胞学确认,不能仅凭PET-CT阳性决定管理。
- 评估时应结合淋巴结大小和SUV值,以提高恶性判断的特异性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is routinely used to evaluate mediastinal lymph nodes (LNs), especially for cancer staging. There are limited large studies evaluating the cytologic, radiologic, and clinical features of 18F-fluorodeoxy glucose positron emission tomography-computed tomography-positive (PET-CT+) LNs. OBJECTIVE.—: To compare cytologic, radiologic, and clinical features of PET-CT+, cytology-malignant (PET-CT+/Cyto+) and PET-CT+, cytology-benign (PET-CT+/Cyto-) LNs. DESIGN.—: The pathology database was searched for cases of mediastinal LNs obtained by EBUS-TBNA from January 1, 2015 to December 31, 2015. The cytologic, radiologic, and clinical features were collected for all PET-CT+ LNs. RESULTS.—: Of 2267 mediastinal LNs obtained by EBUS-TBNA during this period, 577 LNs met the criteria. Of the latter, 263 (46%) were PET-CT+/Cyto+ and 314 (54%) were PET-CT+/Cyto-. All of the patients with PET-CT+/Cyto+ results had a prior or concurrent diagnosis of malignancy as compared to 89% of patients with PET-CT+/Cyto- results. Of the 224 patients with PET-CT+/Cyto+ LNs, 177 (79%) had metastases from lung primary, 43 (19%) had metastases from nonlung primaries, and 7 (3%) had lymphoma. Average LN size was larger in the PET-CT+/Cyto+ group than in the PET-CT+/Cyto- group (14.6 mm versus 9.58 mm), and mean standardized uptake value in PET-CT+/Cyto+ LNs was higher than that of PET-CT+/Cyto- LNs (10.05 versus 5.99). Significant cytologic findings in PET-CT+/Cyto- cases were necrosis and granulomatous inflammation, including 3 cases with fungal organisms. CONCLUSIONS.—: PET-CT positivity alone was nonspecific for malignancy and insufficient to guide management of patients with mediastinal adenopathy, but specificity could be improved when combined with LN size and standardized uptake value.
引用
- Gan Q, Stewart JM, Valik E, et al. Cytologic Evaluation of Positron Emission Tomography-Computed Tomography-Positive Lymph Nodes Sampled by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Experience at a Large Cancer Center. Arch Pathol Lab Med. 2019. PMID: 31063012. doi:10.5858/arpa.2018-0483-OA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。